| Primary |
| Depression |
31.8% |
| Schizophrenia |
22.7% |
| Bipolar Disorder |
9.1% |
| Mental Disorder |
9.1% |
| Affective Disorder |
4.5% |
| Anxiety |
4.5% |
| Hyperthyroidism |
4.5% |
| Insomnia |
4.5% |
| Severe Mental Retardation |
4.5% |
| Stress |
4.5% |
|
| Intentional Overdose |
9.1% |
| Weight Decreased |
9.1% |
| Arteriosclerosis |
4.5% |
| Condition Aggravated |
4.5% |
| Diabetes Mellitus |
4.5% |
| Dizziness |
4.5% |
| Haematospermia |
4.5% |
| Ill-defined Disorder |
4.5% |
| Incorrect Dose Administered |
4.5% |
| Knee Operation |
4.5% |
| Parkinson's Disease |
4.5% |
| Parkinsonism |
4.5% |
| Priapism |
4.5% |
| Somnolence |
4.5% |
| Suicide Attempt |
4.5% |
| Tardive Dyskinesia |
4.5% |
| Trance |
4.5% |
| Tremor |
4.5% |
| Visual Disturbance |
4.5% |
| Weight Increased |
4.5% |
|
| Secondary |
| Depression |
27.2% |
| Drug Use For Unknown Indication |
18.4% |
| Tuberculosis |
10.5% |
| Convulsion |
7.0% |
| Hypertension |
4.4% |
| Insomnia |
4.4% |
| Schizophrenia |
4.4% |
| Bipolar Disorder |
3.5% |
| Dementia Alzheimer's Type |
3.5% |
| Product Used For Unknown Indication |
3.5% |
| Epilepsy |
1.8% |
| Hallucination |
1.8% |
| Mental Retardation Severity Unspecified |
1.8% |
| Peritoneal Dialysis |
1.8% |
| Psychotic Disorder |
1.8% |
| Affective Disorder |
0.9% |
| Agitation |
0.9% |
| Anxiety |
0.9% |
| Attention Deficit/hyperactivity Disorder |
0.9% |
| Extrapyramidal Disorder |
0.9% |
|
| Drug Hypersensitivity |
13.2% |
| Weight Decreased |
13.2% |
| Suicide Attempt |
7.9% |
| Visual Disturbance |
7.9% |
| Optic Neuritis |
5.3% |
| Respiratory Failure |
5.3% |
| Torsade De Pointes |
5.3% |
| Ventricular Fibrillation |
5.3% |
| Weight Increased |
5.3% |
| Wound Haemorrhage |
5.3% |
| Arteriosclerosis |
2.6% |
| Diabetes Insipidus |
2.6% |
| Failure To Thrive |
2.6% |
| Hepatitis |
2.6% |
| Insomnia |
2.6% |
| Long Qt Syndrome |
2.6% |
| Optic Neuropathy |
2.6% |
| Pain In Extremity |
2.6% |
| Polyneuropathy |
2.6% |
| Posture Abnormal |
2.6% |
|
| Concomitant |
| Depression |
14.9% |
| Bipolar Disorder |
9.1% |
| Anxiety |
8.3% |
| Sleep Disorder |
7.5% |
| Arthritis |
7.4% |
| Product Used For Unknown Indication |
6.5% |
| Antidepressant Therapy |
4.8% |
| Schizophrenia |
4.7% |
| Schizoaffective Disorder |
4.6% |
| Pain |
4.3% |
| Mental Disorder |
4.1% |
| Drug Use For Unknown Indication |
3.7% |
| Osteoporosis |
3.1% |
| Gastric Disorder |
2.7% |
| Agitation |
2.6% |
| Hypertension |
2.6% |
| Diabetes Mellitus |
2.4% |
| Routine Health Maintenance |
2.4% |
| Smoking Cessation Therapy |
2.3% |
| Mineral Supplementation |
2.0% |
|
| Weight Increased |
17.1% |
| Type 2 Diabetes Mellitus |
16.3% |
| Vomiting |
7.0% |
| Weight Decreased |
7.0% |
| Urinary Tract Infection |
5.4% |
| Diabetes Mellitus |
4.7% |
| Tardive Dyskinesia |
4.7% |
| Mental Disorder |
3.9% |
| Suicidal Ideation |
3.9% |
| Dizziness |
3.1% |
| Hypotension |
3.1% |
| Skin Lesion |
3.1% |
| Tremor |
3.1% |
| Tricuspid Valve Incompetence |
3.1% |
| Vaginal Infection |
3.1% |
| Death |
2.3% |
| Myocardial Infarction |
2.3% |
| Obesity |
2.3% |
| Osteonecrosis |
2.3% |
| Rash Maculo-papular |
2.3% |
|
| Interacting |
| Convulsion |
66.7% |
| Drug Use For Unknown Indication |
33.3% |
|
| Thrombosis |
50.0% |
| Weight Increased |
50.0% |
|
